Feature Articles

  1. BioPharma Industry Getting Comfortable With Complex Single-Use Devices
    2/10/2012
    The rate of usage of disposables in biopharmaceutical manufacturing has increased substantially over the past six years in a variety of areas, but most notably for complex devices, that are also among the most expensive. By Eric Langer
  2. Avoiding A Failed NDA Submission Via A Third-Party Gatekeeper
    2/9/2012
    Companies specializing in the development, registration, and manufacture of pharmaceuticals will require no less than flawless management of data and tactical tasks to meet stringent FDA NDA (new drug application) submission requirements. By Diane Mauriello and William Cairns
  3. Single-Use Technologies Applied Throughout The Development And Manufacturing Of Biopharmaceuticals
    2/7/2012
    While much has been written about specific applications of single-use technologies (SUT) in biopharmaceutical production, the breadth of their involvement is sometimes overlooked. From the earliest thaws of frozen cells to the final filling of protein-product solutions, SUT are in widespread use. By Michiel Ultee, Laureate Biopharmaceutical Services
  4. A Single-Use Bioreactor For Both Cell And Microbial Cultures: A Dream Becomes Reality
    2/2/2012
    Application of single-use equipment is common practice in the biopharmaceutical industrial and academic field. Compared to the traditional glass or stainless steel bioreactors, single-use bioreactors offer clear advantages. By Nico M.G. Oosterhuis, Frank H. van Dongen, CELLution Biotech BV
  5. Trends And Challenges In Bioresearch: Part II Chromatographic Analysis And Characterization Of Protein-Based Drugs
    2/1/2012
    The commercial drug pipeline has made a dramatic shift from conventional small-molecule drugs to biologic-based pharmaceuticals in the past five years. By Tom Ricci
  6. Characterisation Of Two Single-Use Bioreactors For Mammalian Cell Culture Processes
    2/1/2012
    Single-use cell culture bioreactors based on disposable product-contacting equipment increasingly replace established stainless steel systems.
  7. Pharma R&D Productivity Drops 70%
    1/27/2012
    You have to spend money to make money. But, for the pharma industry, the return has been less than robust these last six years. By Cindy Dubin
  8. Efficient Contracting Processes For Clinical Trials ... From The Legal Perspective
    1/27/2012
    On Dec. 1, 2011 in Cambridge, MA, law firm Pepper Hamilton's Timothy Atkins, partner, life sciences, and Jason Reiser, associate, life sciences, gave a presentation as part of the firm's Life Sciences Speaker Series. By Sara Gambrill
  9. Cleave Biosciences: From Concept To Biotech Start-Up
    1/27/2012
    "You have to be comfortable with chaos when your company's bank account goes from $0 to $44 million overnight," says Laura Shawver, CEO of Cleave Biosciences, which received series A funding in Sept. 2011. By Fred Olds
  10. Building A Biotech In China
    1/27/2012
    Pharmaceutical and biotech companies are looking to emerging markets as the next frontier for drug development, discovery, and perhaps, the next breakthrough. By Rob Wright

First 1 2 3 4 5 6 7 8 9 10 10 (Last)